Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Insulin derivatives having an extremely delayed time-action profile

Insulin derivatives having an extremely delayed time-action profile

US Patent 9644017 · Granted May 9, 2017

Estimated economic value: $33,626,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

FGFR1/KLB targeting agonistic antigen-binding proteins and conjugates thereof wi2024
Insulin analogs with reduced affinity to insulin receptor and use thereof2022
FGF21 variants2022
FGF21 variants2022
Insulin conjugates2021
Conjugates of a pharmaceutical agent and a moiety capable of binding to a glucos2021
Conjugates of a pharmaceutical agent and a moiety capable of binding to a glucos2021
Expression and folding in the manufacturing process of CD-RAP by using a CD-RAP 2020
FGF21 compound / GLP-1R agonist combinations with optimized activity ratio2020
Combination of an insulin and a GLP-1 agonist2018
Combination of an insulin and a GLP-1-agonist2016
Long-acting formulations of insulin2016